A Prospective Treatment for Selective Mutism through an Analysis of Social Anxiety Disorder
DOI:
https://doi.org/10.47611/jsrhs.v11i3.3236Keywords:
selective mutism, social anxiety disorder, treatment, antidepressants, SNRIsAbstract
Selective mutism (SM) is a rare pediatric anxiety disorder in which a child fails to speak in specific social situations. Due to its classification as a rare disorder that affects less than 1% of the world’s population, research on this disorder is limited, inhibiting available treatment options for SM patients. Thus, it is critical to research more on this relatively unexplored disorder. Social anxiety disorder (SAD) is a prevalent anxiety disorder characterized by the fear, self-consciousness, and embarrassment in social situations in which a person may be judged or evaluated negatively. SM is known to present with other anxiety disorders, primarily SAD. The main treatment for SM is cognitive-behavioral therapy (CBT), followed by pharmacological interventions such as selective serotonin reuptake inhibitors (SSRIs). With limited knowledge of this rare disorder, this paper attempts to suggest a potential novel treatment for SM, serotonin-norepinephrine reuptake inhibitors (SNRIs). SNRIs are a class of antidepressants used to increase both an individual’s serotonin and norepinephrine levels in the brain. Previous case studies of SM and research on these specific antidepressants used commonly to treat comorbid SAD elucidate the antidepressant’s potential on SM. With its strong usage in the treatment of SAD, SNRIs may also be effective as a treatment for SM, a disorder that has similar clinical presentations and therapeutic approaches to SAD. In conclusion, this review paper calls to attention the lack of research on SM and identifies a novel alternative approach for its effective treatment.
Downloads
References or Bibliography
Allgulander, C., Hackett, D., & Salinas, E. (2001). Venlafaxine Extended Release (ER) in the Treatment of Generalised Anxiety Disorder: Twenty-four-week placebo-controlled dose-ranging study. The British Journal of Psychiatry, 179(1), 15–22. https://doi.org/10.1192/bjp.179.1.15
Allgulander, C., Mangano, R., Zhang, J., Dahl, A. A., Lepola, U., Sjödin, I., Emilien, G., & SAD 388 Study Group. (2004). Efficacy of Venlafaxine ER in patients with social anxiety disorder: A double-blind, placebo-controlled, parallel-group comparison with paroxetine. Human Psychopharmacology, 19(6), 387–396. https://doi.org/10.1002/hup.602
Alyanak, B., Kılınçaslan, A., Harmancı, H. S., Demirkaya, S. K., Yurtbay, T., & Vehid, H. E. (2013). Parental adjustment, parenting attitudes and emotional and behavioral problems in children with selective mutism. Journal of Anxiety Disorders, 27(1), 9–15. https://doi.org/10.1016/j.janxdis.2012.10.001
American Psychiatric Association (Ed.). (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (5th ed).
Arie, M., Henkin, Y., Lamy, D., Tetin-Schneider, S., Apter, A., Sadeh, A., & Bar-Haim, Y. (2007). Reduced auditory processing capacity during vocalization in children with Selective Mutism. Biological Psychiatry, 61(3), 419–421. https://doi.org/10.1016/j.biopsych.2006.02.020
Bar-Haim, Y., Henkin, Y., Ari-Even-Roth, D., Tetin-Schneider, S., Hildesheimer, M., & Muchnik, C. (2004). Reduced auditory efferent activity in childhood selective mutism. Biological Psychiatry, 55(11), 1061–1068. https://doi.org/10.1016/j.biopsych.2004.02.021
Black, B., & Uhde, T. W. (1992). Elective mutism as a variant of social phobia. Journal of the American Academy of Child and Adolescent Psychiatry, 31(6), 1090–1094. https://doi.org/10.1097/00004583-199211000-00015
Black, B., & Uhde, T. W. (1994). Treatment of elective mutism with fluoxetine: A double-blind, placebo-controlled study. Journal of the American Academy of Child and Adolescent Psychiatry, 33(7), 1000–1006. https://doi.org/10.1097/00004583-199409000-00010
Black, B., & Uhde, T. W. (1995). Psychiatric characteristics of children with selective mutism: A pilot study. Journal of the American Academy of Child and Adolescent Psychiatry, 34(7), 847–856. https://doi.org/10.1097/00004583-199507000-00007
Blanco, C., Bragdon, L. B., Schneier, F. R., & Liebowitz, M. R. (2013). The evidence-based pharmacotherapy of social anxiety disorder. International Journal of Neuropsychopharmacology, 16(1), 235–249. https://doi.org/10.1017/S1461145712000119
Brix Andersson, C., & Hove Thomsen, P. (1998). Electively mute children: An analysis of 37 Danish cases. Nordic Journal of Psychiatry, 52(3), 231–238. https://doi.org/10.1080/08039489850139157
Brown, B., Fuller, J., & Gericke, C. (1975). Elective mutism: A review and a report of an unsuccessfully treated case. Journal of the Association of Workers for Maladjusted Children, 3, 49–63.
Carbone, D., Schmidt, L. A., Cunningham, C. C., McHolm, A. E., Edison, S., St. Pierre, J., & Boyle, M. H. (2010). Behavioral and Socio-emotional Functioning in Children with Selective Mutism: A Comparison with Anxious and Typically Developing Children Across Multiple Informants. Journal of Abnormal Child Psychology, 38(8), 1057–1067. https://doi.org/10.1007/s10802-010-9425-y
Chavira, D. A., Shipon-Blum, E., Hitchcock, C., Cohan, S., & Stein, M. B. (2007). Selective Mutism and Social Anxiety Disorder: All in the Family? Journal of the American Academy of Child & Adolescent Psychiatry, 46(11), 1464–1472. https://doi.org/10.1097/chi.0b013e318149366a
Chu, A., & Wadhwa, R. (2022). Selective Serotonin Reuptake Inhibitors. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK554406/
Cohan, S. L., Chavira, D. A., Shipon-Blum, E., Hitchcock, C., Roesch, S. C., & Stein, M. B. (2008). Refining the classification of children with selective mutism: A latent profile analysis. Journal of Clinical Child and Adolescent Psychology: The Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53, 37(4), 770–784. https://doi.org/10.1080/15374410802359759
Cohan, S. L., Chavira, D. A., & Stein, M. B. (2006). Practitioner review: Psychosocial interventions for children with selective mutism: a critical evaluation of the literature from 1990-2005. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 47(11), 1085–1097. https://doi.org/10.1111/j.1469-7610.2006.01662.x
Crumley, F. E. (1990). The masquerade of mutism. Journal of the American Academy of Child & Adolescent Psychiatry, 29(2), 318–319. https://doi.org/10.1097/00004583-199003000-00031
Cunningham, C. E., McHolm, A., Boyle, M. H., & Patel, S. (2004). Behavioral and emotional adjustment, family functioning, academic performance, and social relationships in children with selective mutism: Selective mutism. Journal of Child Psychology and Psychiatry, 45(8), 1363–1372. https://doi.org/10.1111/j.1469-7610.2004.00327.x
Davidson, J. R., DuPont, R. L., Hedges, D., & Haskins, J. T. (1999). Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. The Journal of Clinical Psychiatry, 60(8), 528–535. https://doi.org/10.4088/jcp.v60n0805
Dell’Osso, B., Buoli, M., Baldwin, D. S., & Altamura, A. C. (2010). Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: A comprehensive review of their clinical efficacy. Human Psychopharmacology: Clinical and Experimental, 25(1), 17–29. https://doi.org/10.1002/hup.1074
Dow, S. P., Sonies, B. C., Scheib, D., Moss, S. E., & Leonard, H. L. (1995). Practical Guidelines for the Assessment and Treatment of Selective Mutism. Journal of the American Academy of Child & Adolescent Psychiatry, 34(7), 836–846. https://doi.org/10.1097/00004583-199507000-00006
Driessen, J., Blom, J. D., Muris, P., Blashfield, R. K., & Molendijk, M. L. (2020). Anxiety in Children with Selective Mutism: A Meta-analysis. Child Psychiatry & Human Development, 51(2), 330–341. https://doi.org/10.1007/s10578-019-00933-1
Dummit, E. S., Klein, R. G., Tancer, N. K., Asche, B., Martin, J., & Fairbanks, J. A. (1997). Systematic assessment of 50 children with selective mutism. Journal of the American Academy of Child and Adolescent Psychiatry, 36(5), 653–660. https://doi.org/10.1097/00004583-199705000-00016
Edison, S. C., Evans, M. A., McHolm, A. E., Cunningham, C. E., Nowakowski, M. E., Boyle, M., & Schmidt, L. A. (2011). An investigation of control among parents of selectively mute, anxious, and non-anxious children. Child Psychiatry and Human Development, 42(3), 270–290. https://doi.org/10.1007/s10578-010-0214-1
Feighner, J. P. (1999). Mechanism of action of antidepressant medications. The Journal of Clinical Psychiatry, 60 Suppl 4, 4–11; discussion 12-13.
Fung, D. S. S., Manassis, K., Kenny, A., & Fiksenbaum, L. (2002). Web-based CBT for selective mutism. Journal of the American Academy of Child and Adolescent Psychiatry, 41(2), 112–113. https://doi.org/10.1097/00004583-200202000-00003
Garakani, A., Murrough, J. W., Freire, R. C., Thom, R. P., Larkin, K., Buono, F. D., & Iosifescu, D. V. (2020). Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Frontiers in Psychiatry, 11. https://www.frontiersin.org/articles/10.3389/fpsyt.2020.595584
Gelenberg, A. J., Lydiard, R. B., Rudolph, R. L., Aguiar, L., Haskins, J. T., & Salinas, E. (2000). Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial. JAMA, 283(23), 3082–3088. https://doi.org/10.1001/jama.283.23.3082
Gensthaler, A., Khalaf, S., Ligges, M., Kaess, M., Freitag, C. M., & Schwenck, C. (2016). Selective mutism and temperament: The silence and behavioral inhibition to the unfamiliar. European Child & Adolescent Psychiatry, 25(10), 1113–1120. https://doi.org/10.1007/s00787-016-0835-4
Goll, K. (1979). Role structure and subculture in families of elective mutism. Family Process, 18, 55–68.
Golwyn, D. H., & Weinstock, R. C. (1990). Phenelzine treatment of elective mutism: A case report. The Journal of Clinical Psychiatry, 51(9), 384–385.
Hackett, D., Haudiquet, V., & Salinas, E. (2003). A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder. European Psychiatry: The Journal of the Association of European Psychiatrists, 18(4), 182–187. https://doi.org/10.1016/s0924-9338(03)00046-4
Henkin, Y., Feinholz, M., Arie, M., & Bar-Haim, Y. (2010). P50 suppression in children with selective mutism: A preliminary report. Journal of Abnormal Child Psychology, 38(1), 43–48. https://doi.org/10.1007/s10802-009-9346-9
Herjanic, B., & Campbell, W. (1977). Differentiating psychiatrically disturbed children on the basis of a structured interview. Journal of Abnormal Child Psychology, 5(2), 127–134. https://doi.org/10.1007/BF00913088
Hofmann, S. G., Asnaani, A., Vonk, I. J. J., Sawyer, A. T., & Fang, A. (2012). The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses. Cognitive Therapy and Research, 36(5), 427–440. https://doi.org/10.1007/s10608-012-9476-1
Jakubovski, E., Johnson, J. A., Nasir, M., Müller-Vahl, K., & Bloch, M. H. (2019). Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders. Depression and Anxiety, 36(3), 198–212. https://doi.org/10.1002/da.22854
Kaakeh, Y., & Stumpf, J. L. (2008). Treatment of Selective Mutism: Focus on Selective Serotonin Reuptake Inhibitors. Pharmacotherapy, 28(2), 214–224. https://doi.org/10.1592/phco.28.2.214
Kearney, C. A., & Rede, M. (2021). The Heterogeneity of Selective Mutism: A Primer for a More Refined Approach. Frontiers in Psychology, 12. https://www.frontiersin.org/article/10.3389/fpsyg.2021.700745
Kristensen, H. (2000). Selective mutism and comorbidity with developmental disorder/delay, anxiety disorder, and elimination disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 39(2), 249–256. https://doi.org/10.1097/00004583-200002000-00026
Krohn, D. D., Weckstein, S. M., & Wright, H. L. (1992). A study of the effectiveness of a specific treatment for elective mutism. Journal of the American Academy of Child and Adolescent Psychiatry, 31(4), 711–718. https://doi.org/10.1097/00004583-199207000-00020
Kumpulainen, K. (2002). Phenomenology and Treatment of Selective Mutism: CNS Drugs, 16(3), 175–180. https://doi.org/10.2165/00023210-200216030-00004
Lambert, O., & Bourin, M. (2002). SNRIs: Mechanism of action and clinical features. Expert Review of Neurotherapeutics, 2(6), 849–858. https://doi.org/10.1586/14737175.2.6.849
Lang, C., Nir, Z., Gothelf, A., Domachevsky, S., Ginton, L., Kushnir, J., & Gothelf, D. (2016). The outcome of children with selective mutism following cognitive behavioral intervention: A follow-up study. European Journal of Pediatrics, 175(4), 481–487. https://doi.org/10.1007/s00431-015-2651-0
Leichsenring, F., & Leweke, F. (2017). Social Anxiety Disorder. New England Journal of Medicine, 376(23), 2255–2264. https://doi.org/10.1056/NEJMcp1614701
Liebowitz, M., & Mangano, R. (2002, June 10). Venlafaxine XR in generalized social anxiety disorder [poster].
Liebowitz, M. R., Gelenberg, A. J., & Munjack, D. (2005). Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder. Archives of General Psychiatry, 62(2), 190–198. https://doi.org/10.1001/archpsyc.62.2.190
Liebowitz, M. R., Heimberg, R. G., Fresco, D. M., Travers, J., & Stein, M. B. (2000). Social Phobia or Social Anxiety Disorder: What’s in a Name? Archives of General Psychiatry, 57(2), 191–192.
Manassis, K., Tannock, R., Garland, E. J., Minde, K., McINNES, A., & Clark, S. (2007). The Sounds of Silence: Language, Cognition, and Anxiety in Selective Mutism. Journal of the American Academy of Child & Adolescent Psychiatry, 46(9), 1187–1195. https://doi.org/10.1097/CHI.0b013e318076b7ab
Muris, P., & Ollendick, T. H. (2015). Children Who are Anxious in Silence: A Review on Selective Mutism, the New Anxiety Disorder in DSM-5. Clinical Child and Family Psychology Review, 18(2), 151–169. https://doi.org/10.1007/s10567-015-0181-y
Muris, P., & Ollendick, T. H. (2021).
Current Challenges in the Diagnosis and Management of Selective Mutism in Children
. Psychology Research and Behavior Management, 14, 159–167. https://doi.org/10.2147/PRBM.S274538Nowakowski, M. E., Tasker, S. L., Cunningham, C. E., McHolm, A. E., Edison, S., Pierre, J. St., Boyle, M. H., & Schmidt, L. A. (2011). Joint Attention in Parent–Child Dyads Involving Children with Selective Mutism: A Comparison Between Anxious and Typically Developing Children. Child Psychiatry & Human Development, 42(1), 78–92. https://doi.org/10.1007/s10578-010-0208-z
Oerbeck, B., Stein, M. B., Pripp, A. H., & Kristensen, H. (2015). Selective mutism: Follow-up study 1 year after end of treatment. European Child & Adolescent Psychiatry, 24(7), 757–766. https://doi.org/10.1007/s00787-014-0620-1
Orvaschel, H., & Puig-Anrich, J. (1987). Schedule for Affective Disorders and Schizophrenia for School-Age Children: Epidemiologic Version. Medical College of Pennsylvania, Eastern Pennsylvania Psychiatric Institute.
Preskorn, S. H. (1997). Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Clinical Pharmacokinetics, 32 Suppl 1, 1–21. https://doi.org/10.2165/00003088-199700321-00003
Pustrom, E., & Speers, R. W. (1964). Elective mutism in children. Journal of the American Academy of Child Psychiatry, 3, 287–297.
Reuther, E. T., Davis III, T. E., Moree, B. N., & Matson, J. L. (2011). Treating Selective Mutism Using Modular CBT for Child Anxiety: A Case Study. Journal of Clinical Child & Adolescent Psychology, 40(1), 156–163. https://doi.org/10.1080/15374416.2011.533415
Rickels, K., Mangano, R., & Khan, A. (2004). A Double-Blind, Placebo-Controlled Study of a Flexible Dose of Venlafaxine ER in Adult Outpatients With Generalized Social Anxiety Disorder. Journal of Clinical Psychopharmacology, 24(5), 488–496. https://doi.org/10.1097/01.jcp.0000138764.31106.60
Rickels, K., Pollack, M. H., Sheehan, D. V., & Haskins, J. T. (2000). Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder. The American Journal of Psychiatry, 157(6), 968–974. https://doi.org/10.1176/appi.ajp.157.6.968
Rosenberg, J. B., & Linblad, M. B. (1978). Behavior therapy in a family context: Treating elective mutism. Family Process, 17, 77–82.
Silverstone, P. H. (2004). Qualitative Review of SNRIs in Anxiety. 10.
Stein, M. B., Pollack, M. H., Bystritsky, A., Kelsey, J. E., & Mangano, R. M. (2005). Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: A 6-month randomized controlled trial. Psychopharmacology, 177(3), 280–288. https://doi.org/10.1007/s00213-004-1957-9
Steinhausen, H. C., & Juzi, C. (1996). Elective mutism: An analysis of 100 cases. Journal of the American Academy of Child and Adolescent Psychiatry, 35(5), 606–614. https://doi.org/10.1097/00004583-199605000-00015
Vecchio, J., & Kearney, C. A. (2009). Treating youths with selective mutism with an alternating design of exposure-based practice and contingency management. Behavior Therapy, 40(4), 380–392. https://doi.org/10.1016/j.beth.2008.10.005
Vecchio, J. L., & Kearney, C. A. (2005). Selective Mutism in Children: Comparison to Youths With and Without Anxiety Disorders. Journal of Psychopathology and Behavioral Assessment, 27(1), 31–37. https://doi.org/10.1007/s10862-005-3263-1
Wong, P. (2010). Selective Mutism. Psychiatry (Edgmont), 7(3), 23–31.
Wright, H. L. (1968). A clinical study of children who refuse to talk in school. Journal of the American Academy of Child Psychiatry., 7, 603–617.
Xue, W., Wang, P., Li, B., Li, Y., Xu, X., Yang, F., Yao, X., Chen, Y. Z., Xu, F., & Zhu, F. (2016). Identification of the inhibitory mechanism of FDA approved selective serotonin reuptake inhibitors: An insight from molecular dynamics simulation study. Physical Chemistry Chemical Physics: PCCP, 18(4), 3260–3271. https://doi.org/10.1039/c5cp05771j
Young, B. J., Bunnell, B. E., & Beidel, D. C. (2012). Evaluation of Children With Selective Mutism and Social Phobia: A Comparison of Psychological and Psychophysiological Arousal. Behavior Modification, 36(4), 525–544. https://doi.org/10.1177/0145445512443980
Published
How to Cite
Issue
Section
Copyright (c) 2022 Riya Patel; Lauren Kirk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
